Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Get the latest news and real-time alerts from Decoy Therapeutics Inc. (DCOY) stock at Seeking Alpha.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results